HIGHLIGHTS
- who: Am. J. Trop. Med. and collaborators from the Health Institute, University of Antwerp, Antwerp, BelgiumTown, South Africa have published the research: Papers that have been accepted for publication are peer-reviewed and copy edited but do not incorporate all corrections or constitute the final versions that will appear in the Journal, in the Journal: (JOURNAL) of February/19,/2020
- what: This study supports the safety tolerability and feasibility of PfSPZ Challenge by DVI for evaluating the blood-stage activity of candidate antimalarial drugs. infectious PfSPZ (PfSPZ Challenge) which are introduced via intradermal injection 17 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.